Insider Transactions in Q4 2025 at Bio Xcel Therapeutics, Inc. (BTAI)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35
+0.54%
|
-
|
|
Dec 15
2025
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35
+0.51%
|
-
|
|
Dec 15
2025
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35
+0.53%
|
-
|
|
Dec 15
2025
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
219
+1.04%
|
-
|
|
Dec 14
2025
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33
+0.51%
|
-
|
|
Dec 14
2025
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33
+0.49%
|
-
|
|
Dec 14
2025
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33
+0.5%
|
-
|
|
Dec 14
2025
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
164
+0.79%
|
-
|
|
Oct 31
2025
|
David J. Mack Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,694
+7.7%
|
-
|